Alison P. Klein

Bloomberg (United States)

Full Professor(heuristic)

Pancreatic and Hepatic Oncology Research · Oncology

h-index76

i10-index169

Publications548

Citations36,912

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 98

Supplementary Table 2 from Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors
2026-06-17
Supplementary Table 1 from Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors
2026-06-17
Supplementary Table 3 from Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors
2026-06-17
Pancreatic cancer.
Apollo (University of Cambridge) · 2026-05-07
Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals
medRxiv · 2026-04-22
Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus
medRxiv · 2026-03-04
Supplementary Table S4 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Figure S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S8 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S3 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S9 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S1 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S5 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table S10 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table 3 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26
Supplementary Table 5 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26
Supplementary Table 6 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26
Supplementary Table S7 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025-11-26
Supplementary Table 2 from Relationship between <i>ABO</i> Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (<i>FUT2</i>) Genotype, but Not Lewis Antigen (<i>FUT3</i>) Genotype
2025-11-26

Open author page on OpenAlex →